Symptomatic diagnosis of prostate cancer in primary care: a structured review
- PMID: 15296564
- PMCID: PMC1324845
Symptomatic diagnosis of prostate cancer in primary care: a structured review
Abstract
Background: Prostate cancer has the second highest cancer incidence and mortality in European men. Most prostate cancers are diagnosed after lower urinary tract symptoms (LUTS) are presented to primary care, but such symptoms more often have a benign cause. A general practitioner (GP) has to try and identify which of these patients have prostate cancer.
Aims: To review the presenting features of symptomatic prostate cancer.
Design of study: Structured review.
Method: We searched Medline from 1980 to 2003 for symptoms, signs, and investigations reported in prostate cancer. This list was then expanded by secondary searches of reference lists. We excluded studies on post-diagnostic topics, such as staging, treatment, and prognosis; studies on non-Western patients; and studies on investigations that are not available in primary care. A second cycle of exclusions removed studies whose results would not guide a GP in deciding whether a patient has prostate cancer.
Results: No studies from primary care compared prostate cancer patients directly with controls. Two secondary care studies had enough information to allow a comparison of symptoms in cases compared with controls. In these studies, symptoms were generally more prevalent in cases, but the differences were small. Screening and secondary care studies suggest that early prostate cancer is symptomless, and that locally advanced cancer has LUTS that are similar to those for benign prostatic hypertrophy.
Conclusion: There is a very weak evidence base for the primary care diagnosis of prostate cancer in men with lower urinary tract symptoms.
Similar articles
-
Clinical features of prostate cancer before diagnosis: a population-based, case-control study.Br J Gen Pract. 2006 Oct;56(531):756-62. Br J Gen Pract. 2006. PMID: 17007705 Free PMC article.
-
Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptoms.J Clin Epidemiol. 2007 Feb;60(2):176-80. doi: 10.1016/j.jclinepi.2006.05.011. Epub 2006 Sep 28. J Clin Epidemiol. 2007. PMID: 17208124
-
Diagnosing prostate cancer - what GPs need to know.Aust Fam Physician. 2007 May;36(5):345-7. Aust Fam Physician. 2007. PMID: 17492070 Review.
-
Screening by lower urinary tract symptoms vs asymptomatic prostate-specific antigen levels leading to radical prostatectomy in Danish men: tumour characteristics and treatment outcome.BJU Int. 2009 Jul;104(2):205-8. doi: 10.1111/j.1464-410X.2008.08306.x. Epub 2009 Jan 12. BJU Int. 2009. PMID: 19154477
-
5alpha-reductase inhibition for men with enlarged prostate.J Am Acad Nurse Pract. 2007 Aug;19(8):398-407. doi: 10.1111/j.1745-7599.2007.00243.x. J Am Acad Nurse Pract. 2007. PMID: 17655569 Review.
Cited by
-
Bone marrow fibrosis and metastatic prostate adenocarcinoma.BMJ Case Rep. 2012 Dec 12;2012:bcr2012007348. doi: 10.1136/bcr-2012-007348. BMJ Case Rep. 2012. PMID: 23235102 Free PMC article.
-
Cancer diagnosis in primary care.Br J Gen Pract. 2010 Feb;60(571):121-8. doi: 10.3399/bjgp10X483175. Br J Gen Pract. 2010. PMID: 20132704 Free PMC article. Review.
-
Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients.Res Rep Urol. 2017 Feb 23;9:27-35. doi: 10.2147/RRU.S125791. eCollection 2017. Res Rep Urol. 2017. PMID: 28261572 Free PMC article.
-
Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study.Ther Adv Urol. 2017 Jun 21;9(7):179-190. doi: 10.1177/1756287217712379. eCollection 2017 Jul. Ther Adv Urol. 2017. PMID: 28747996 Free PMC article.
-
Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project.J Epidemiol. 2017 Mar;27(3S):S65-S70. doi: 10.1016/j.je.2016.12.008. Epub 2017 Feb 17. J Epidemiol. 2017. PMID: 28215481 Free PMC article.
References
-
- Sakr WA, Haas GP, Cassin BF, et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 1993;150:379–385. - PubMed
-
- Murphy M, Johnston C, Whelan P, et al. Changing trends in prostatic cancer. BJU Int. 1999;83:786–791. - PubMed
-
- Tannock I. Eradication of a disease: how we cured symptomless prostate cancer. Lancet. 2002;359:1341–1342. - PubMed
-
- Quinn M, Babb P, Brock A, et al. Cancer trends in England and Wales 1950–1999. London: The Stationery Office; 2001. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=4822 (accessed 22 Jun 2004)
-
- Horwich A, Waxman J, Abel P, et al. Tumours of the prostate. In: Souhami R, Tannock I, Hohenberger P, Horiot J-C, editors. The Oxford textbook of oncology. 2nd edn. Oxford: Oxford University Press; 2001. pp. 1939–1971.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials